Sign in
CompletedNo phase

Development and Validation of an Interpretable Machine Learning Model for Predicting Venous Thromboembolism(VTE)in Intensive Care Unit (ICU) Patients

Key facts

Who runs it
Beijing Tsinghua Chang Gung Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
12,061 people enrolled
Started
1 Jan 2022
Ended
31 Dec 2025
Type of study
Observational
Record updated
19 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • age ≥18 years
  • ICU length of stay ≥48 hour
  • the first ICU admission

Who cannot take part

  • VTE diagnosed prior to ICU admission
  • VTE diagnosed within 24 hours of ICU admission
  • >20% missing values in key variables

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Venous thromboembolism remains a leading cause of preventable mortality in intensive care unit (ICU) patients. Existing risk-stratification tools were developed in general medical populations and lack ICU-specific predictors. This study was to develop and validate an interpretable machine learning (ML) model to predict VTE in ICU patients.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
19 May 2026